Skip to content

AUTL - Autolus Therapeutics plc - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchA

Autolus Therapeutics Ltd

AUTL · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

A

AUTLAutolus Therapeutics Ltd

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $2.58
52-wk low: $1.18
Prev close: $2.00
Mkt cap: $676.1M
Beta: 2.00
P/S: 626.9x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$14.6M

JS
Jim Simons
Q2 2026 13F
$3.2M
position
MI
Millennium
Israel Englander · Q2 2026 13F

Earnings

Reported Aug 11, 2026

Earnings came in 28.6% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $676M

Valuation

P/S626.85
P/B8.16

Quality

Operating margin-6571.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: AUTL
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $676.05M
Beta: 2.00

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

8.2x

Profit margin

+0.0%

Op margin

-6571.0%

ROE

-29.6%

$2.0M

position

BA

Balyasny

Dmitry Balyasny · Q2 2026 13F

$1.6M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for AUTL

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.15+28.6%

-$0.21 expected

Next report

What the street expects next

EPS expected

-$0.19

-$0.24 to -$0.15

Revenue expected

$35.9M

6 analysts

Last 30 days

6up0down

Analysts raising estimates

Estimate drift

+0.02

Change in 30 days

-29.6%

ROA-22.3%

Growth

Beta2.00